Abstract
Mannitol has been used for the reduction of raised intracranial pressure (ICP) for years, however, the most effective dose and the method of administration have remained controversial [2, 3]. One of the reasons is that the pharmacokinetics of mannitol has not been clearly understood in relation to the changes of mannitol concentration and serum osmolality and the decrease of ICP after the mannitol administration [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Cloyd JC, Synder BD, Cleeremans B, Bundie SR (1986) Mannitol pharmacokinetics and serum osmolality in dogs and humans. J Pharmacol Exp Ther 23:301–306
Marshall LF, Smith RW, Rausher LA, Shapiro HM (1978) Mannitol dose requirements in brain injured patients. J Neurosurg 48:169–172
Roberts PA, Pollay M, Engles C, Pendleton B, Reynolds E, Stevens FL (1987) Effect on intercranial pressure of furosemide combined with various dose and administration rates of mannitol. J Neurosurg 66:440–446
Yamaoka K (1984) Method of pharmacokinetic analysis by personal computer. Nanzando, Tokyo
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Takagi, H., Tanaka, M., Ohwada, T., Tomonaga, F. (1993). Pharmacokinetic Analysis of Mannitol in Relation to the Decrease of ICP. In: Avezaat, C.J.J., van Eijndhoven, J.H.M., Maas, A.I.R., Tans, J.T.J. (eds) Intracranial Pressure VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77789-9_129
Download citation
DOI: https://doi.org/10.1007/978-3-642-77789-9_129
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77791-2
Online ISBN: 978-3-642-77789-9
eBook Packages: Springer Book Archive